ACUNAV Luxera 4D ICE Catheter
Siemens Medical Solutions USA, Inc. · Decision date Sep 10, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on September 10, 2026 for the ACUNAV Luxera 4D ICE Catheter, submitted by Siemens Medical Solutions USA, Inc. under K261696. The submission is a Special 510(k) for a Class II diagnostic intravascular catheter, product code OBJ, regulation 21 CFR 870.1200, in the cardiovascular specialty. The device is described as a 13.5F catheter with 90 cm usable length and four-way steering that provides real-time three-dimensional ultrasound images alongside conventional two-dimensional images. SESE denotes 510(k) clearance, not PMA approval.
The submission states substantial equivalence to the applicant's previously cleared ACUSON AcuNav Volume ICE catheter (K212959), with indications for use unchanged from that predicate. The comparison table lists differing tip dimensions (13.5F versus 12.5F) and acoustic array (96 channel on ASIC versus 192 channel Vector). The summary states clinical data were not required to establish substantial equivalence. The source does not disclose the specific design changes underlying the Special 510(k) or any performance test results.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 10, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261696
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Siemens Medical Solutions USA, Inc.
- Product code
- OBJ
- Decision code
- SESE
- Decision date
- Sep 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Catheter, Ultrasound, Intravascular.
- Applicant
- Siemens Medical Solutions USA, Inc.
- Product code
- OBJ
- FDA device class
- 2
FDA decision timeline
K261696 received
Application receipt date recorded by FDA.
K261696 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OBJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Luma Vision Limited | 510(k) clearance | Jul 24, 2026 | FDA | |
Novasight Hybrid SystemK252945 | Conavi Medical, Inc. | 510(k) clearance | Apr 17, 2026 | FDA |
| Boston Scientific | 510(k) clearance | Apr 8, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Siemens Medical Solutions USA, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Issaquah, WA
Sources and methodology
- Original FDA record: K261696
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
